in

Why Harris is still at risk in swing states

Save over 65%

$99 for your first year

FT newspaper delivered Monday-Saturday, plus FT Digital Edition delivered to your device Monday-Saturday.

Analysis-Europe in no hurry to loosen antitrust stance

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough